Lilly(Eli) Profit Margin

The latest profit margin for LLY is 31.86% as of September 2026. That compares with 30.99% in the prior-year period — up 2.8% year over year. That is above the Healthcare sector average of 9.48%. Investors often review this figure alongside Lilly(Eli)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, LLY's profit margin moved from 30.99% to 31.86% — a 2.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Lilly(Eli)'s valuation or profitability profile.

Against Healthcare companies, LLY currently prints 31.86% for profit margin, while the sector average sits near 9.48%. That is roughly 236.1% above the sector mean. Large gaps often invite a closer look at Lilly(Eli)'s growth, margins, and balance sheet.

Profit Margin shows how effectively Lilly(Eli) converts resources into returns. At 31.86%, LLY may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with 30.99% in the prior-year period — up 2.8% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting LLY's profit margin (31.86%), review year-over-year change from 30.99%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.